BIOTRONIK SE & Co. KG · Coronary Drug-Eluting Stent · First cleared Sep 2024
Total Reports
583
Reports (30d)
27
Active Signals
2
Open Recalls
0
What the reports describe · Claripulse analysis
Inability to Cross Severely Calcified Lesion
stent selected, mission, mission drug, orsiro mission, orsiro
53
reports
Shaft Break During Withdrawal
synergy, lesion located, shaft, completed, synergy drug
1
reports
Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.
Detection
Keep exploring
Perclose ProGlide
ABBOTT VASCULAR INC. · 24,552 reports
Perclose ProStyle
ABBOTT VASCULAR INC. · 19,404 reports
PERCLOSE
ABBOTT VASCULAR INC. · 9,941 reports
Angio-Seal
TERUMO MEDICAL CORPORATION · 6,506 reports
SYNERGY
BOSTON SCIENTIFIC CORPORATION · 6,023 reports
Resolute Onyx
MEDTRONIC, INC. · 4,474 reports
Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 2 active signals detected right now.
Get Early AccessUnderstanding this data